Deciphering the immune reaction leading to spontaneous melanoma regression: initial role of MHCII+ CD163− macrophages
Open Access
- 1 August 2023
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 72 (11) , 3507-3521
Abstract
The human cutaneous metastatic melanoma is the deadliest skin cancer. Partial, or less frequently complete spontaneous regressions could be observed, mainly mediated by T cells. Nevertheless, the underlying mechanisms are not fully unraveled. We investigated the first events of the immune response related to cancer regression in Melanoma-bearing Libechov Minipigs (MeLiM), a unique swine model of cutaneous melanoma that regresses spontaneously. Using a multiparameter flow cytometry strategy and integrating new clinical and histological criteria of the regression, we show that T cells and B cells are present only in the late stages, arguing against their role in the initial destruction of malignant cells. NK cells infiltrate the tumors before T cells and therefore might be involved in the induction of the regression process. Myeloid cells represent the main immune population within the tumor microenvironment regardless of the regression stage. Among those, MHCII+ CD163− macrophages that differ phenotypically and functionally compared to other tumor-associated macrophages, increase in number together with the first signs of regression suggesting their crucial contribution to initiating the regression process. Our study supports the importance of macrophage reprogramming in humans to improve current immunotherapy for metastatic melanoma.Keywords
Funding Information
- Institut National Du Cancer (project MeLiMun)
This publication has 51 references indexed in Scilit:
- Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node StatusJAMA Dermatology, 2015
- Macrophages and Therapeutic Resistance in CancerCancer Cell, 2015
- NK cell-based immunotherapy for malignant diseasesCellular & Molecular Immunology, 2013
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic MelanomaCancer Research, 2012
- IL4I1: an inhibitor of the CD8+ antitumor T‐cell response in vivoEuropean Journal of Immunology, 2011
- The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesLeukemia, 2009
- Surface NK receptors and their ligands on tumor cellsSeminars in Immunology, 2006
- Direct evidence to support the immunosurveillance concept in a human regressive melanoma.Journal of Clinical Investigation, 1994
- Histological regression in primary cutaneous melanoma: recognition, prevalence and significanceHistopathology, 1992
- Prognosis in patients with thin malignant melanoma: influence of regressionHistopathology, 1983